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In  1913,  Steinhardt,  Israeli,  and  Lambert (1)  demonstrated that 
vaccine virus is  capable of multiplication in  the presence of bits  of 
viable tissue embedded in plasma.  Although this work has been con- 
firmed by a number of investigators, cultures of vaccine virus made by 
means of the cover-slip  technique have proved of no  value  in  the 
preparation of an active agent for Jennerian prophylaxis.  In  1927, 
Carrel and Rivers (2) devised a method for the cultivation of vaccine 
virus in which bits of viable chick embryo tissue embedded  in plasma in 
flasks were used.  In 1928,  Maitland and Maitland  (3)  showed that 
they were able to grow vaccine virus in a medium consisting of minced 
hen kidney suspended in a mixture of hen serum and Tyrode's solu- 
tion.  In  1929,  Rivers,  Haagen,  and  Muckenfuss (4)  demonstrated 
that cells remain viable for at least 5 days in a medium made accord- 
ing to Maitland's directions.  However, if the cells are killed by re- 
peated freezing and thawing, the medium no longer supports the mul- 
tiplication of virus. 
In a further search for a simple and safe method of cultivating vac- 
cine virus for human use,  we devised a  highly satisfactory medium 
which consists of bits of minced chick embryo tissue  (0.1  gin.)  sus- 
pended in Tyrode's solution (4--5 cc.) in "collar flasks."  In 1930, the 
results obtained with cultures of a  neurovaccine virus were reported 
(5).  In 1931, we described (6) our work with a dermal strain of vac- 
cine virus and reported that the culture virus had been successfully 
used for the vaccination of 3 children.  In 1932, Herzberg (7) reported 
that he had been able to vaccinate human beings with virus cultivated 
in the manner described by us.  Since our last report in 1931 we have 
continued our observations, and it seems appropriate at this time to 
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record certain facts that have accumulated in  regard to the culture 
virus and its use for Jennerian prophylaxis. 
One of the objects of our work on the cultivation of vaccine virus 
has been to obtain an active agent, free from bacteria and contaminat- 
ing viruses, that will protect human beings against smallpox with the 
least amount of inconvenience and discomfort to the individuals vac- 
cinated.  Consequently, all cultures of virus used in this type of work 
have been carefully tested for the presence of bacteria and other unde- 
sirable agents. 
EXPERIMENTAL 
As we have been able to show (5, 6) that vaccine virus will multiply 
in the presence of bits of minced chick embryo tissue  (0.1  gin.)  and 
Tyrode's  solution  (4-5  cc.),  we  decided  to  determine what  would 
happen to the active agent when it was cultivated in such a medium 
over a long period of time.  This was accomplished by making trans- 
fers in series from old cultures to flasks of fresh medium at intervals 
of 4 or 5 days and then testing the activity of the virus in the different 
culture passages  by means of dermal and intradermal titrations  in 
rabbits and vaccination of human beings. 
Effect of in  Vitro  Cultivation  on the Activity of Vaccine  Virus in 
the Rabbit 
Cultures of vaccine virus were initiated,  March 9,  1931,  and the 
titer in rabbits of the active agent in the 1st set of cultures was 10 -6. 
The titer of the virus in the 19th set of cultures was 10 -e, in the 30th 
10-*, in the 60th 10 -3, in the 80th 10 -2, in the 86th 10 -1.  From the 
88th set of cultures to the 99th only the undiluted virus produced a 
lesion when injected intradermally.  From the record portrayed  in 
Chart 1 it can be seen that the titer of the virus in the cultures main- 
tained a high level, around 10 -6, for 19 generations and then gradually 
fell until only the undiluted cultures in the 88th generation produced 
a lesion in rabbits. 
With the drop in the titer of the virus in the rabbit came a change 
in  the  character of the  lesions  induced by  the  active  agent.  The 
virus in the first 15 generations upon intradermal inoculation produced 
large edematous lesions with hemorrhagic and necrotic centers.  With THOMAS  M.  RIVERS  AND  S.  M.  WARD  637 
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material from the 15th to the 70th generations nodular lesions without 
hemorrhage and  necrosis were excited.  When  the virus was  spread 
on  the  scarified  skin,  however,  typical  vaccinal  vesicles  appeared. 
After the 73rd generation, only small fiat red areas 1 cm. in diameter 
were seen at the points of intradermal inoculation of the virus.  The 
erythema faded rapidly and was followed by a superficial scaling of the 
skin.  Upon dermal inoculation of the virus, only a  slight amount of 
redness and scaling was produced which was almost indistinguishable 
from that caused by scarification alone.  In spite of the fact that ex- 
tremely mild  and  evanescent lesions  were produced in  rabbits  with 
material from these cultures, vaccine virus was present in them as will 
be seen when the reaction induced by them in human beings is dis- 
cussed. 
Revival  of the Activity  of Culture  Virus by  Means  of Testicular 
Passages in Rabbits 
Inasmuch as vaccine virus for human use is usually tested in rabbits 
before distribution, we have attempted to obtain a culture strain  that 
retains  its pathogenicity both for man  and  rabbits.  Consequently, 
when  the  titer of the  culture virus  for the  rabbit  began  to  fall,  we 
passed the virus through several rabbits by means of testicular inocu- 
lations.  With the passaged virus new cultures were  initiated.  This 
procedure has been resorted to three times and the results are detailed 
below and portrayed in  Chart 1. 
1 cc. of the pooled 34th generation cultures was injected into each testicle of a 
rabbit.  After 4 days the testicles were removed aseptically and an emulsion was 
prepared.  1 cc. of this emulsion was then injected into each testicle of another 
rabbit.  This procedure was repeated until the virus had been passed through 6 
rabbits.  All of the animals had fever.  The titer of the virus gradually increased 
and the intradermal lesions again assumed a hemorrhagic and necrotic character. 
With testicular virus from the 6th rabbit new cultures were initiated and have been 
designated  as the 1st revived strain.  The titer of the first  14 generations  of this 
strain was  10  -6,  the intradermal lesions were edematous, hemorrhagic,  and nec- 
rotic.  Upon further passage of the virus in cultures the titer gradually fell (Chart 
1)  and the character of the lesions  changed  from hemorrhagic and necrotic to 
nodular, 
1 cc. of the pooled cultures of the 31st generation of the 1st revived strain was 
injected into each testicle of a rabbit.  After 4 days the testicles were removed and THOMAS ~.  RIWRS A~D  S.  ~.  WARD  639 
an emulsion was made.  1 cc. of this emulsion was injected  into each testicle  of 
another rabbit.  This procedure  was repeated until  the virus had been passed 
through 3 rabbits.  All of the animals had fever and typical vaccinal reactions in 
the testicles.  Testicular  virus from the 3rd rabbit was used to start a new set of 
cultures  that has been designated  as the 2nd revived  strain.  The titer of this 
strain has remained  around 10  -6 for 60 culture generations.  Although the titer 
has not fallen to any great extent (Chart 1), the intradermal lesions have become 
less hemorrhagic  and more nodular. 
Repeated passages of vaccine virus in the culture medium used in 
this work appear  to  decrease  the  titer  of the  active agents for rab- 
bits  and to mitigate the  severity of the lesions produced.  We have 
been able in the manner described above to revive the culture strains 
by testicular passages in rabbits,  and the 2nd revived strain seems to 
be fairly stable.  It may be necessary, however, to repeat the proce- 
dure of revival several times more before a  completely stable  culture 
virus is obtained. 
The original culture  strain  (Chart  1)  was  carried for more than  2 
years without being revived by passage  through  rabbits.  The  88th 
culture passage produced little  or no reaction in the skin of a  rabbit 
yet produced typical vaccinal reactions in the skin of 2 children.  It 
seemed of interest to find out if this culture could be revived by pas- 
sages through rabbits. 
1 cc. of the pooled cultures of the 88th passage (original strain) was injected into 
each testicle of a rabbit.  The culture virus was also rubbed into the scarified skin 
and injected  intradermaUy.  Only a slight papule appeared at the point of intra- 
dermal inoculation and no definite vaccinal lesions were seen in the area of scarifi- 
cation during the 7 day period of observation.  The animal had no fever.  Never- 
theless, the testicles were removed on the 4th day after inoculation and appeared 
practically  normal.  An emulsion  of  the  testicles  was  made and  1 cc.  of  the 
emulsion was injected into each testicle of another rabbit.  Dermal and intrader- 
real inoculations were also made.  The testicles were removed on the 4th day and 
seemed  slightly  injected.  At  the  point  of  intradermal  inoculation  a lesion, 1 
x 1 era. in diameter,  developed and 2 discrete pocks were seen in the area of dermal 
inoculation.  The testicular  virus was passed  to a 3rd rabbit that developed no 
fever.  The testicles  in this  animal  had the appearance  of being  affected by a 
mild vaccinia.  At the site of intradermal  inoculation a lesion, 6 x 5 cm. in diame- 
ter, developed, and 2 discrete pocks were observed in the scarified skin.  The 4th 
rabbit  had fever,  inflamed  testicles,  confluent  vaccinal  eruption at  the  site  of 
scarification,  and an intradermal  titer of the virus of 10 -8.  The 5th rabbit had 
fever, inflamed testicles, and an intradermal  titer of the virus of 10  -~.  The 6th 640  CULTIVATION  OF VACCINE  VIRUS 
rabbit had fever and the  testicles were inflamed.  From an emulsion of the tes- 
ticles of the 6th rabbit, cultures were initiated  and have been designated as the 
3rd revived strain.  The titer of the 1st culture was 10 -s, of the 2nd 10 -e, of the 
4th 10 -5, and of the 7th 10 -4 (Chart 1). 
From the facts presented above it appears  that  the 88th  culture 
passage of the original strain of culture virus caused little or no reac- 
tion in rabbits.  Upon repeated testicular passages in rabbits,  how- 
ever, the virus gradually regained its pathogenicity for that host. 
TABLE  I 
Summary  of Results  of Vaccinations  in Man witk ttte Original  Culture Strain 
of Virus 
No. of  Culture 
patients  passage 
12  11 
1  11 
1  11 
1  14 
1  14 
1  42 
1  42 
1  42 
1  82 
1  82 
1  86 
1  88 
1  88 
Preservation  of culture 
Time  Manner 
1  mo. 
2 days 
11  " 
2  wks. 
3  " 
6 mos. 
19  " 
1 hr. 
1 wk. 
2 wks. 
1 too. 
39 days 
1 hr. 
]  " 
1  " 
Glycerol at  +3°C. 
,,  ,,  +3° ,, 
,,  ,,  _]_3  ° ,, 
,,  ,,  +3 ° ,, 
,,  ,,  +3 o,, 
Glycerol at -- 10°C. 
,,  ,,  _  i0  °  ,, 
Glycerol at  +3°C. 
.  ,,  +3 ° ,, 
.  ,,  +3 ° - 
.  ,,  +3 ° - 
,,  .  +3 o,, 
Without glycerol at +3°C. 
....  ,,  +3 ° ,, 
,,  ,,  .  +3 ° ,, 
Results 
+ 
+ 
12+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Revaccina- 
tlon with 
New York 
City virus 
+ 
Jennerian Prophylaxis in Man by Means o/Culture Virus 
Before discussing the effect that in vitro cultivation has on the ac- 
tivity of vaccine virus in man it seems advisable to present in tabular 
form the results obtained in individuals vaccinated with culture virus. 
With the original strain,  25 people have been inoculated (Table I). 
Of these, only 1 failed to  develop a  typical vaccinal lesion.  Six of 
the individuals who reacted to  the culture virus were revaccinated 
with the New York City Board of Health virus and were found to be 
refractory.  With the 2nd revived strain  (Table II),  77 people have THOMAS  M.  RIVERS  AND  S.  M.  WARD  641 
TABLE  II 
S**mmary of Results of Vaccinations  in Man with the 2nd Revived Culture Strain 
of Virus 
No. of 
patients 
II 
19 
Culture 
passage 
272 
332 
36, 
422 
42, 
422 
422 
42, 
432 
44s 
472 
422 
49, 
492 
512 
492 
51, 
50s 
512 
542 
562 
Preservation of culture 
Time  Manner 
1 too, 
2 wks. 
.3  " 
4  days 
1 wk. 
11 days 
1 too. 
1  " 
2 wks. 
6 days 
3 wks. 
2  mos. 
1 too. 
4 days 
4  " 
1 hr. 
4 days 
1 hr. 
1 day 
4 days 
3  " 
3  hrs. 
Glycerol at +3°C. 
Dessiccated 
~¢ 
Glycerol at +3°C. 
.  ,,  +3° - 
....  +3 ° ,, 
.  ,,  +3 ° - 
.  .  +3  o- 
,,  ,,  +3° ,, 
Without glycerol at +3°C. 
Glycerol at +3°C. 
.  ,,  +3 ° ,, 
.  ,,  +3 ° ,, 
.  ,,  +3 ° ,, 
,,  ,,  +3 o- 
Without glycerol at +3°C. 
Glycerol at +3°C. 
Without glycerol at +3°C. 
Glycerol at +3°C. 
.  ,,  +3 ° ,, 
.  .  +3 ° ,, 
.  ,,  +3 ° ,, 
Resu] Ls 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
2+ 
2- 
S+ 
+ 
6+ 
2- 
8+ 
3- 
+ 
+ 
+ 
1- 
9--I- 
7+ 
1- 
15+ 
4- 
Revacclna- 
tion with 
New York 
City virus 
+ 
TABLE  III 
Summary of Results of Vaccinations  in Man with the 3rd Revi~ed Culture Strain 
of Virus 
Preservation of culture 
Results  No. of patients  Culture passage 
"lime  Manner 
16  5s  4 hrs.  Glycerol at +3°C.  12+ 
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been vaccinated,  64 of whom developed typical vaccinal lesions.  Of 
those who had reactions, 2 were revaccinated with the New York City 
Board of Health  virus and  were found  to be refractory.  With  the 
3rd  revived strain  (Table III),  16  individuals  have been inoculated 
and in  12 of them typical ivaccinal  reactions  occurred.  Three  chil- 
dren  who had  been vaccinated with  the  New  York  City  Board  of 
Health  virus  were found  to  be refractory  to  the  culture  virus.  In 
summary,  118 individuals have been inoculated with the culture virus 
and in 100 of them the inoculation was foUowed by a typical vaccinal 
pustule.  Individuals  vaccinated with  the  culture virus were refrac- 
tory to a  standard dermal strain of calf lymph and vice versa.  All of 
the inoculations  represent primary vaccinations  in infants  and  chil- 
dren.  Approximately one-third of the patients  were in the Hospital 
of The Rockefeller Institute for complete observation during the course 
of the vaccination.  The other two-thirds were vaccinated by us in Dr. 
Schloss' prophylactic clinic at the  Cornell Medical Center  and  were 
seen only once after inoculation. 
Effect of in Vitro Cultivation on the Activity of Vaccine Virus 
in Man 
With  virus from  the  5th,  10th,  and  llth  culture  passages  of the 
original  strain  15  children  were  vaccinated.  A  positive  result  was 
obtained  in  each  individual.  The  reactions  were  similar  to  those 
caused by the New York City Board of Health virus.  Consequently, 
no  more  children  were  vaccinated  with  the  virus  until  it had  been 
passed through  42 successive sets of cultures.  Then virus from the 
42nd, 82nd, 86th, and 88th sets of cultures were tested in man  (Table 
I).  In  addition  to this,  virus from cultures of the  2nd  and 3rd  re- 
vived strains  (Tables II and III)  were employed for the vaccination 
of a large number of children.  Virus from these cultures did not aver- 
age as high a percentage of positive reactions as that usually obtained 
with the New York City Board of Health virus.  The reactions, how- 
ever,  were milder  than  those  caused by the  Board of Health  virus; 
the children had no fever and were in no way upset.  In every respect 
the results obtained with the culture virus were highly satisfactory. 
During  the course of the observations it was found that  with  the 
later  generations  of  culture  virus  an  area  of  skin  larger  than  that THOMAS  M.  RIVERS  AND  S.  M.  WARD  643 
usually advised had to be scarified in order to insure a  positive reac- 
tion.  Furthermore, it  soon became evident that  fresh culture virus 
(Tables  I,  II,  and  III)  can be used  with  complete safety.  Such is 
not the  case  with  green  calf lymph.  Moreover,  in  view of our  ex- 
perience with the culture virus,  we  suggest  that  it  be  dispensed  in 
cork-stoppered vials containing enough material for 10 vaccinations in- 
stead of in capillary tubes containing only sufficient virus for 1 inocu- 
lation.  This  suggestion  is made  because  the  culture virus  contains 
a  very  small  amount  of  particulate  matter  and  it  is  believed  that 
sooner or later the virus is adsorbed on these particles which in turn 
tend to adhere to the sides of the capillary tubes.  Under these con- 
ditions difficulty is encountered in expressing the virus from the tubes 
and a low percentage of positive reactions is likely to be obtained. 
Vaccination by Means of Intradermal  Injection of Culture Virus 
The  results  of intradermal  vaccinations  have been  reported by a 
number of workers.  The literature has been fully reviewed in a  com- 
munication  by Roberts  (8).  In  spite  of the  favorable  reports con- 
cerning the matter, most physicians have hesitated to use this method 
because of the fact that very few vaccine virus preparations  are en- 
tirely free from living bacteria.  Inasmuch as we had a  bacteria-free 
virus that caused mild reactions upon dermal inoculation, we decided 
to see what it would do when injected intradermally into man. 
C. B. received intradermaUy 0.1 cc. of a 1-10 dilution of culture 422 that had 
been preserved for 11 days in 50 per cent neutral glycerol at  +3°C.  The first 
signs of a reaction were observed 9 days later and consisted  of erythema and a 
slight amount of induration.  The erythema spread and the induration increased 
for a few days and then gradually disappeared,  No pustule formed and no scar 
was left.  The child was not sick or upset and had no fever.  Upon revaecination 
with the New York City Board of Health virus the child was found to be refractory. 
R. R. received intradermally 0.1 cc. of a 1-10 dilution of culture 423 that had 
been preserved for 1 month in 50 per cent neutral glycerol at  q-3°C,  The first 
signs of a  reaction were seen on the 7th day after inoculation.  The course of 
events was practically the same as that described for C. B. with the exception that 
a very small vesicle formed where the  needle was  inserted in the skin.  Upon 
revaccination the child was found to be refractory. 
J. O'B. received intradermally 0.1 cc. of a 1-10 dilution of culture 442 that had 
been preserved without glycerol for 6 days at -k3°C.  The first signs of a reaction 
were observed on the 4th day following inoculation.  The course of events was the 644  CULTIVATION  OF  VACCINE  VIRUS 
same as that described  for R.R.  The small  vesicle  resulted in a minute scar. 
Upon revaccination the child was found to be refractory. 
H. J. received intradermally 0.1 cc. of undiluted fresh culture 88.  On the 4th 
day after inoculation a red papule was seen.  The course of events was similar to 
that of the other children.  No pustule formed and no scar was left.  Upon re- 
vaccination the child proved to be refractory. 
From  the  facts presented  above it  appears  that  intradermal  vac- 
cination  with  virus  that  has  been  passed  through  a  number of cul- 
tures  is  safe.  The  virus  can  be  used,  undiluted  or  diluted  1-10,  in 
0.1 cc. amounts either in the fresh or preserved state. 
Effect of Storage  on the Titer of Culture  Virus 
It was essential to determine how well the cu]ture virus withstands 
storage.  Consequently,  lots  of  the  same  virus  were  preserved  in 
different ways and later tested in rabbits for potency. 
One lot of virus was mixed with an equal amount of 100 per cent neutral glycerol, 
another lot with an equal amount of 100 per cent neutral glycerol to which  heated 
normal chick embryo tissue had been added, and still another lot with an  equal 
amount of 100 per cent glycerol to which sufificient  glucose had been added to make 
a 2.5 per cent solution.  Then these lots of virus were placed in small cork-stop- 
pered vials.  Half of each lot of vials was stored at -  10°C., the other half at +3°C. 
From time to time a vial of each lot was removed from storage and the virus was 
titered intradermally in rabbits. 
The results of the work described above are shown in Table IV and 
indicate that the titer of the culture virus in storage ( -  10°C. and -b 3°C.) 
gradually fell from 10 -6 but was still  10 -4 at the end of a year.  Fur- 
thermore, virus in a  vial that had been stored at  -  10°C. for 19 months 
produced a  typical vaccinal lesion in a  child. 
Desiccation of the Culture  Virus 
Vaccine virus does not maintain its activity well in the absence of 
refrigeration.  It has been shown,  however, that a  number of viruses 
retain their activity better if they are frozen and then desiccated while 
in the frozen state.  In view of this fact we performed an experiment 
in  which  culture  virus  (36th passage of the  2nd  revived strain)  was 
frozen,  desiccated,  and  then  stored  in  sealed  tubes  at  37°C.  Each 
week for 5 weeks a  tube was removed from the incubator, the original THOMAS  M.  RIVERS  AND  S. M.  WARD  645 
volume in the tube was restored with sterile distilled water,  and the 
resulting  virus mixture  was titered intradermally  in  a  rabbit.  The 
results are brought together in Table V and show that the dried virus 
TABLE  IV 
Effect  of Storage  on  Titer  of  Culture  Virus  (14th  Generation  of  Original  Culture 
Strain) 
Time in 
storage 
Titer by cal- 
culation be- 
fore storage 
1 day 
1 mo. 
3  mos. 
5  " 
1 yr. 
19 mos. 
Stored at --I0°C. in cork-stoppered  vials  Stored at +3°C. in cork-stoppercd vials 
Equal volume of 
glycerol added 
to culture 
500,000 
100,000 
1,000,000 
100,000 
10,000 
E. Ramon  + 
Equal volume 
of glycerol 
added to 
culture plus 
extra heated 
iembryo  tissue 
1,000,000 
1,000,000 
1,000,000 
10,000 
10,000 
Equal volume 
of glycerol 
added to 
culture 
containing 
2.5 per cent 
glucose 
500,000 
1,000,000 
1,000,000 
10,000 
10,000 
100,000 
100,000 
10,000 
10,000 
ual vol  me [Equal volume 
Equal  ~q"  1 c  U l  I  ofglycerol 
volume of  ot giy ero  ]  added to  au(lel2 to 
glycerol  culture plus  c Cnt~lUmr'eI 
added to  extra heated  ~ o  ng 
culture  "r  o ""  ue  I z.5 ~er cent  cmo y  tlSS  .  ~[uccse 
500,000  I  500,000 
1,000,00C 
1,000,00C 
100,000  1,000,000 
10,000 
10,000 
100,000 
1,000 
1,000 
TABLE  V 
Effect  of Storage  at 37°C.  on  Desiccated  Culture  Virus  (36th Generation  of 2nd 
Revived  Strain) 
Time of titration  Intradermal titer 
in rabbits 
Before desiccation ............................................... 
After desiccation ................................................ 
Mter  storage for 1 wk.  at  37°C ................................. 
"  "  "  2  wks.  "  37 °``  ................................ 
"  "  "  3  "  "  37  °''  ................................ 
"  "  "  4  "  "  37 °'' .................................. 
......  5  ....  37 °".  ................................ 
100,000 
100,000 
100,000 
1,000 
1,000 
1,000 
10 
maintained some of its activity for 5 weeks even at 37°C.  In addition 
to this fact we have  shown  (Table II)  that  desiccated culture virus 
restored  to  its  original  volume  with  25  per  cent  glycerol produces 
typical vaccinal lesions in human beings. 646  CULTIVATION  O:F  VACCINE  VIRUS 
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Initiation of New Cultures from Preserved Cultures 
If the cultivation of vaccine virus is to become a practical procedure, 
it is essential to know whether new cultures can be initiated with virus 
from  preserved  cultures.  Therefore,  numerous  attempts  have  been 
made to ascertain the facility with which new cultures can be success- 
fully seeded with virus from cultures that have been frozen and desic- 
cated or from cultures preserved with or without glycerol.  We have 
experienced no  difficulty in obtaining  fresh cultures in this manner. 
For convenience a few of the results are shown in Table VI. 
DISCUSSION 
From the results of the work presented in this paper it is obvious 
that we have had no difficulty in cultivating a dermal strain of vaccine 
virus for a  period of over 2 years in a  medium consisting of bits of 
viable chick embryo tissue (0.i  gin.)  suspended in Tyrode's solution 
(4-5 cc.)  in flasks.  This medium was chosen because it is the least 
likely of all media containing living cells to be contaminated with an 
unknown  or  an  undesirable  virus.  It  is  also  evident  that  culture 
virus has been successfully employed by us for Jennerian prophylaxis 
in man.  It is hoped that our observations will tempt workers in vac- 
cine  virus laboratories  to  try  to  adapt  this  or  a  similar  method  of 
preparation of the active agent for general use.  In view of the purity 
of the virus prepared  in  this manner  and  since it  causes such mild, 
yet effective reactions in man, it seems possible that much of the ob- 
jection to vaccination might be overcome and that the rare but occa- 
sional postvaccinal encephalitis might be rendered even more rare, or 
avoided wholly, by its use instead of that of calf lymph. 
Attention  should be focussed on the fact that repeated cultivation 
of vaccine virus in the medium used by us gradually reduced the titer 
of the active agent for the rabbit and also led to an alteration in the 
type of lesions produced by the virus in that host.  Indeed, the virus 
that had been cultivated for 2 years in the manner described induced 
little  or no reaction  in  rabbits.  Material  from  these cultures,  how- 
ever,  gave  rise  to  typical vaccinal  pustules  in  man.  This  observa- 
tion appears to us to be of importance and among other things seems 
to indicate that  a  virus of a  desired character for human  use can be 
produced by culture methods.  In view of the findings presented  at 648  CULTIVATION OF  VACCINE VIRUS 
this time, it is believed that the change in the activity of the virus for 
the rabbit was not due entirely--and perhaps not at all--to a gradual 
diminution  in the amount of virus in successive sets of cultures,  but 
to some alteration in the character of the virus itself. 
SUMMARY 
A  dermal  strain  of vaccine virus has been passed through  99 suc- 
cessive culture passages.  This procedure led to a  diminution  in the 
pathogenicity of the active agent for the rabbit.  By repeated testicu- 
lar passages in rabbits, however,  the  virus regained its pathogenicity 
for  that  host.  New cultures  were  initiated  with  the  revived virus. 
A  culture strain  of virus that  has been twice revived in this manner 
has remainedfairly  stable for the rabbit through  60 culture passages 
and  it produces mild,  yet effective vaccinal  reactions in man. 
Virus in  early cultures was not attenuated  for man, but later  cul- 
tures of the original  strain  and  cultures of the  2nd  and  3rd revived 
strains produced mild reactions without fever and discomfort to the 
patients.  Intradermal  vaccinations  with  the  culture  virus  are  safe 
and satisfactory. 
With the culture virus 118 infants and children have been inoculated 
and  in  100 of them a  positive reaction occurred.  The  culture virus 
produced a refractory state to a  standard dermal strain of calf lymph 
and vice versa. 
Culture virus stored in  50 per cent neutral  glycerol at  -10°C.  or 
at +3°C. maintained a considerable amount of its activity for at least 
1 year.  Desiccated culture virus sealed in tubes maintained  some of 
its activity when stored at 37°C. for 5 weeks. 
Fresh  cultures  can  be initiated  without  difficulty from desiccated 
virus or from virus that has been stored with or without glycerol. 
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